ArticlePharmaceutics2025

C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences.

Shahab Soltani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.